🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

9,250 results for “IO” Clear

  1. Faceptor

    Biotech Pharmaceutical Co.,

    Breast Cancer Metastatic

    phase 3 small molecule completed

    2 trials

  2. Factor VIII Inhibitor Bypassing Activity (nanofiltered, vapor heat-treated)

    Baxalta Innovations GmbH

    Hemophilia A or B With Inhibitors

    phase 3 mab completed

    1 trial

  3. Fazirsiran Injection

    Takeda

    Alpha1-Antitrypsin Deficiency

    phase 3 small molecule active

    3 trials

  4. Febuxostat

    Takeda

    Cardiovascular Disease

    phase 3 small molecule completed

    1 trial

  5. Felzartamab

    Biogen

    Immunoglobulin A Nephropathy (IgAN)

    phase 3 small molecule active

    1 trial

  6. Femara 2.5 mg film-coated tablets, Cisplatin 1 mg/ml Concentrate for Solution for Infusion, Anastrozole 1mg film-coated tablets, Docetaxel Pfizer 10 mg/mL concentrate for solution for infusion, Paclitaxel 6 mg/ml Concentrate for Solution for Infusion, Exemestane 25 mg Film-coated Tablets, Carboplatin 10 mg/ml Concentrate for Solution for Infusion, Abraxane 5 mg/ml powder for dispersion for infusion.

    Ningbo Cancer Hospital

    low-grade serous carcinoma of the ovary or peritoneum

    phase 3 small molecule active

    1 trial

  7. Fianlimab, LIBTAYO 350 mg concentrate for solution for infusion., Placebo for Fianlimab

    Lacuna Pharma Pty Ltd

    Advanced Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  8. Fibrinogen (human) + thrombin (human) (TachoSil)

    Takeda

    Surgical Resection of Superficial Renal Tumour

    phase 3 other completed

    1 trial

  9. Filgotinib

    Lakefront Biotherapeutics NV

    Psoriatic Arthritis

    phase 3 small molecule terminated

    4 trials

  10. Filgotinib

    Lakefront Biotherapeutics NV

    Ulcerative Colitis

    phase 3 small molecule completed

    2 trials

  11. Filgotinib

    Lakefront Biotherapeutics NV

    Crohn's Disease

    phase 3 small molecule completed

    2 trials

  12. Filgotinib

    Lakefront Biotherapeutics NV

    Ankylosing Spondylitis

    phase 3 small molecule terminated

    3 trials

  13. Film-Coated Tablet without Deucravacitinib, Film-Coated Tablet without JNJ-77242113, DEUCRAVACITINIB, JNJ-77242113

    Janssen-Cilag International N.V.

    Moderate to Severe Plaque Psoriasis

    phase 3 small molecule active

    1 trial

  14. Film-Coated Tablet without JNJ-77242113, JNJ-77242113

    Janssen-Cilag International N.V.

    Plaque Psoriasis

    phase 3 small molecule active

    1 trial

  15. Fimasartan and Rosuvastatin

    Yung NA

    Essential Hypertension, Dyslipidemia

    phase 3 small molecule completed

    1 trial

  16. Finerenone Bayer, Placebo BAY 948862, BAY 94-8862, Placebo BAY 948862 tablets, Finerenone, Finerenone

    Bayer AG

    Heart failure due to systemic left ventricular systolic dysfunction

    phase 3 small molecule active

    1 trial

  17. Finerenone, Finerenone Bayer, BAY 94-8862, Finerenone

    Bayer AG

    Heart failure due to systemic left ventricular systolic dysfunction

    phase 3 small molecule active

    1 trial

  18. Firibastat

    Quantum Biopharma

    Hypertension

    phase 3 small molecule completed

    1 trial

  19. Firibastat (QGC001) Period 1

    Quantum Biopharma

    Hypertension (HTN)

    phase 3 small molecule terminated

    1 trial

  20. Firmonertinib

    ArriVent BioPharma

    Non-Small-Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  21. Firmonertinib

    ArriVent BioPharma

    NSCLC

    phase 3 small molecule active

    1 trial

  22. Fixed Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Use (PH FDC SC)

    Hoffmann-La Roche

    Early Breast Cancer

    phase 3 small molecule completed

    1 trial

  23. Flecainide or Sotalol or Propafenone

    Rhythm Pharmaceuticals Netherlands B.V.

    Paroxysmal Atrial Fibrillation

    phase 3 small molecule completed

    1 trial

  24. Flomoxef

    Takeda

    Urinary Tract Infection

    phase 3 small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources